Avoid doubling doses to 'catch up'that amplifies GI side effects without improving efficacy
In multiple sclerosis models, GLP-1 receptor activation reduces pathogenic Th1 and Th17 cell activity, inhibits microglial activation (the brain equivalent of macrophage inflammation), and may enhance remyelination processes
(E, G) A Boyden chamber assay was used to evaluate the effect of GLP-1 on HUVECs migration
We expect this approach to be useful for the development of peptide therapeutics and we are currently evaluating its generalization to other peptide sequences and protein targets of therapeutic interest
Gergs U, Jung F, Buchwalow IB, Hofmann B, Simm A, Treede H, Neumann J (2017) Pharmacological and physiological assessment of serotonin formation and degradation in isolated preparations from mouse and human hearts
Tesamorelin stimulates additional GH release, but optimizing your natural production through quality sleep enhances overall results